AKTX vs ARGX
Akari Therapeutics PLC · argenx NV ADR
Relative return (rebased to 100)
Key stats
| Metric | AKTX | ARGX |
|---|---|---|
| Price | $9.76 | $959.49 |
| Market Cap | $1.52T | $59.38B |
| P/E | — | 45.96 |
| P/B | 81711.45 | 8.11 |
| P/S | 4130251.34 | 1671.02 |
| ROE | -93.0% | 17.6% |
| Net Margin | -4702.1% | 3636.2% |
| Gross Margin | — | — |
| Revenue Growth | -39.5% | 254.4% |
| Dividend Yield | — | — |
| EPS | -$0.00 | $20.88 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.